Biomednewsbreaks - Lantern Pharma Inc. (LTRN) Expands HARMONICTM Trial To Asia With First ...
Lantern Pharma (LTRN) has enrolled and dosed its first patient in Taiwan for the Phase 2 HARMONICTM trial evaluating LP-300 in never-smokers ...